@article {1632281,
	title = {Imaging diabetic retinal disease: clinical imaging requirements},
	journal = {Acta Ophthalmol},
	volume = {100},
	number = {7},
	year = {2022},
	month = {2022 Nov},
	pages = {752-762},
	abstract = {Diabetic retinopathy (DR) is a sight-threatening complication of diabetes mellitus (DM) and it contributes substantially to the burden of disease globally. During the last decades, the development of multiple imaging modalities to evaluate DR, combined with emerging treatment possibilities, has led to the implementation of large-scale screening programmes resulting in improved prevention of vision loss. However, not all patients are able to participate in such programmes and not all are at equal risk of DR development and progression. In this review, we discuss the relevance of the currently available imaging modalities for the evaluation of DR: colour fundus photography (CFP), ultrawide-field photography (UWFP), fundus fluorescein angiography (FFA), optical coherence tomography (OCT), OCT angiography (OCTA) and functional testing. Furthermore, we suggest where a particular imaging technique of DR may aid the evaluation of the disease in different clinical settings. Combining information from various imaging modalities may enable the design of more personalized care including the initiation of treatment and understanding the progression of disease more adequately.},
	keywords = {Diabetes Mellitus, Diabetic Retinopathy, Diagnostic Techniques, Ophthalmological, Fluorescein Angiography, Humans, Photography, Retinal Vessels, Tomography, Optical Coherence},
	issn = {1755-3768},
	doi = {10.1111/aos.15110},
	author = {Schreur, Vivian and Larsen, Morten B and Sobrin, Lucia and Bhavsar, Abdhish R and den Hollander, Anneke I and Klevering, B Jeroen and Hoyng, Carel B and de Jong, Eiko K and Grauslund, Jakob and Peto, Tunde}
}
